+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Psoriatic Arthritis Treatment Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5733867

Quick Summary:

In an era where psoriatic arthritis remains a persistent health concern, staying informed about the state of the market is paramount. The global psoriatic arthritis treatment market is poised for considerable growth, spurred by the rising prevalence of psoriasis and psoriatic arthritis worldwide. These conditions, known for their severe impairment of health and quality of life, stand to usher in significant demand for effective psoriatic arthritis treatment. A market such as this, marked by millions of patients and an established need, represents a solid area of study for insightful executives.

Strengthen your understanding of the emerging trends and recent developments sweeping across the market. The development of innovative solutions like Janus kinase inhibitors is radically shaping the industry landscape, making the ought-to-know information for strategic decision-makers. Furthermore, key transactions, like Amgen's acquisition of Celgene’s Otezla, point towards ongoing mergers and acquisitions, global expansion, and strategic alliances in this market. A look into our market research report promises to increase your understanding of the key factors underpinning the future of psoriatic arthritis treatment, facilitating informed decision-making and strategic planning.

The psoriatic arthritis treatment market size has grown strongly in recent years. It will grow from $10.93 billion in 2023 to $12 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. Historical growth in psoriatic arthritis treatment can be attributed to several factors. These include an uptick in diagnoses, a growing prevalence of psoriatic arthritis, increased awareness of the condition and its available treatments, a wider range of approved treatments for psoriatic arthritis, government support for research and development initiatives, and augmented investments from pharmaceutical companies. These combined elements contributed to the growth observed in the past period within the realm of psoriatic arthritis treatments.

The psoriatic arthritis treatment market size is expected to see strongly grown in the next few years. It will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. Anticipated growth in the upcoming period is linked to several key factors, including the advancement of personalized medicine, the emergence of new biologics and small molecule treatments, an expansion in the range of available treatment options, and the increasing global aging population's healthcare needs.

The increased prevalence of both psoriasis and psoriatic arthritis has significantly driven the growth of the psoriatic arthritis treatment market. These inflammatory disorders, particularly when occurring together, have a considerable impact on individuals' health and quality of life. Psoriasis, commonly associated with psoriatic arthritis, affects a significant percentage of individuals globally. For instance, in June 2021, the National Psoriasis Foundation reported that over 8 million people in the United States and 125 million worldwide suffered from psoriasis. Furthermore, approximately 30% of individuals with psoriasis in the USA also develop psoriatic arthritis. This rise in prevalence has directly contributed to market expansion.

The surge in healthcare spending has propelled the growth of the psoriatic arthritis treatment market. Increased healthcare expenditure supports various diagnostic procedures, including medical appointments, laboratory tests, and imaging studies essential for confirming diagnoses like psoriatic arthritis. For instance, in the UK, healthcare spending reached around $347.74 billion in 2022, demonstrating a 0.7% nominal increase from the previous year. This increased investment in healthcare resources contributes to the growth of treatments for conditions like psoriatic arthritis. The development of novel drugs like Janus kinase (JAK) inhibitors has significantly shaped the market. JAK inhibitors, such as tofacitinib, baricitinib, and upadacitinib, have emerged as innovative treatments for psoriatic arthritis. These medications have gained approval from regulatory bodies like the FDA and EMA, offering effective options for patients who have had inadequate responses to other treatments.

Major pharmaceutical companies have also been instrumental in market growth by introducing new drugs like Cosentyx. This drug, developed by Novartis, is an interleukin-17A antagonist used to treat various autoimmune diseases, including psoriatic arthritis. In October 2023, its approval by the FDA marked a significant milestone, offering relief for symptoms like joint pain and skin problems associated with psoriatic arthritis.

In February 2023, Takeda Pharmaceutical Company, a Japan-based pharmaceutical company acquired Nimbus Therapeutics for an undisclosed amount. The acquisition is anticipated to improve Takeda Pharmaceutical's position in the market for psoriatic arthritis treatments and broaden its product line. Nimbus Therapeutics is a US-based biotechnology company. It develops drugs for psoriatic arthritis treatment.

Major companies operating in the psoriatic arthritis treatment market include AbbVie Inc., Amgen Astellas BioPharma K.K., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., CB Biosciences Inc., Hoffmann-La Roche Ltd., Merck & Co. Inc., AstraZeneca PLC, Sanofi SA, Otsuka Pharmaceutical Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd., Bayer AG, Abbott Laboratories, Eisai Inc., Janssen Pharmaceuticals Inc., Bausch Health Companies Inc., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Regeneron Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International Inc., Chugai Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd.

North America was the largest region in the psoriatic arthritis treatment market in 2023. The regions covered in the psoriatic arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the psoriatic arthritis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The primary classes of drugs used in psoriatic arthritis treatment encompass nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), biologics, and other medications. Biologic medicines, a subset of treatment options, are substances derived from or containing components of living organisms. These medications can be administered through various routes, including oral, parenteral (injection or infusion), and topical applications. They are distributed through diverse channels such as hospital pharmacies, retail pharmacies, and online pharmacies to cater to the needs of patients undergoing psoriatic arthritis treatment.

The psoriatic arthritis treatment market research report is one of a series of new reports provides psoriatic arthritis treatment market statistics, including global market size, regional shares, competitors with a psoriatic arthritis treatment market share, detailed psoriatic arthritis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the psoriatic arthritis treatment industry. This psoriatic arthritis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The psoriatic arthritis treatment market includes revenues earned by entities by reducing pain and swelling and controlling inflammation and pain. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary2. Psoriatic Arthritis Treatment Market Characteristics3. Psoriatic Arthritis Treatment Market Trends and Strategies
4. Psoriatic Arthritis Treatment Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Psoriatic Arthritis Treatment Market Size and Growth
5.1. Global Psoriatic Arthritis Treatment Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Psoriatic Arthritis Treatment Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Psoriatic Arthritis Treatment Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Psoriatic Arthritis Treatment Market Segmentation
6.1. Global Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
  • Disease-Modifying Anti-Rheumatic Drugs (DMARDS)
  • Biologics
  • Other Drug Classes
6.2. Global Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Parenteral
  • Topical
6.3. Global Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
7. Psoriatic Arthritis Treatment Market Regional and Country Analysis
7.1. Global Psoriatic Arthritis Treatment Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Psoriatic Arthritis Treatment Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Psoriatic Arthritis Treatment Market
8.1. Asia-Pacific Psoriatic Arthritis Treatment Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Psoriatic Arthritis Treatment Market
9.1. China Psoriatic Arthritis Treatment Market Overview
9.2. China Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Psoriatic Arthritis Treatment Market
10.1. India Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Psoriatic Arthritis Treatment Market
11.1. Japan Psoriatic Arthritis Treatment Market Overview
11.2. Japan Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Psoriatic Arthritis Treatment Market
12.1. Australia Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Psoriatic Arthritis Treatment Market
13.1. Indonesia Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Psoriatic Arthritis Treatment Market
14.1. South Korea Psoriatic Arthritis Treatment Market Overview
14.2. South Korea Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Psoriatic Arthritis Treatment Market
15.1. Western Europe Psoriatic Arthritis Treatment Market Overview
15.2. Western Europe Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Psoriatic Arthritis Treatment Market
16.1. UK Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Psoriatic Arthritis Treatment Market
17.1. Germany Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Psoriatic Arthritis Treatment Market
18.1. France Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Psoriatic Arthritis Treatment Market
19.1. Italy Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Psoriatic Arthritis Treatment Market
20.1. Spain Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Psoriatic Arthritis Treatment Market
21.1. Eastern Europe Psoriatic Arthritis Treatment Market Overview
21.2. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Psoriatic Arthritis Treatment Market
22.1. Russia Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Psoriatic Arthritis Treatment Market
23.1. North America Psoriatic Arthritis Treatment Market Overview
23.2. North America Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Psoriatic Arthritis Treatment Market
24.1. USA Psoriatic Arthritis Treatment Market Overview
24.2. USA Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Psoriatic Arthritis Treatment Market
25.1. Canada Psoriatic Arthritis Treatment Market Overview
25.2. Canada Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Psoriatic Arthritis Treatment Market
26.1. South America Psoriatic Arthritis Treatment Market Overview
26.2. South America Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Psoriatic Arthritis Treatment Market
27.1. Brazil Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Psoriatic Arthritis Treatment Market
28.1. Middle East Psoriatic Arthritis Treatment Market Overview
28.2. Middle East Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Psoriatic Arthritis Treatment Market
29.1. Africa Psoriatic Arthritis Treatment Market Overview
29.2. Africa Psoriatic Arthritis Treatment Market, Segmentation by Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Psoriatic Arthritis Treatment Market, Segmentation by Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Psoriatic Arthritis Treatment Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Psoriatic Arthritis Treatment Market Competitive Landscape and Company Profiles
30.1. Psoriatic Arthritis Treatment Market Competitive Landscape
30.2. Psoriatic Arthritis Treatment Market Company Profiles
30.2.1. AbbVie Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Amgen Astellas BioPharma K.K.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Johnson & Johnson Services Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Bristol-Myers Squibb Company
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Celgene Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Psoriatic Arthritis Treatment Market Competitive Benchmarking32. Global Psoriatic Arthritis Treatment Market Competitive Dashboard33. Key Mergers and Acquisitions in the Psoriatic Arthritis Treatment Market
34. Psoriatic Arthritis Treatment Market Future Outlook and Potential Analysis
34.1 Psoriatic Arthritis Treatment Market in 2028 - Countries Offering Most New Opportunities
34.2 Psoriatic Arthritis Treatment Market in 2028 - Segments Offering Most New Opportunities
34.3 Psoriatic Arthritis Treatment Market in 2028 - Growth Strategies
34.3.1 Market Trend-based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic and Forecast Inflation Rates
35.4. Research Inquiries
35.5. About the Analyst
35.6. Copyright and Disclaimer

Executive Summary

Psoriatic Arthritis Treatment Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on psoriatic arthritis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for psoriatic arthritis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Scope


Markets Covered:

1) by Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDS); Disease-Modifying Anti-Rheumatic Drugs (DMARDS); Biologics; Other Drug Classes
2) by Route of Administration: Oral; Parenteral; Topical
3) by Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Key Companies Mentioned: AbbVie Inc.; Amgen Astellas BioPharma K.K.; Johnson & Johnson Services Inc.; Bristol-Myers Squibb Company; Celgene Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Amgen Astellas BioPharma K.K.
  • Johnson & Johnson Services Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Novartis International AG
  • Eli Lilly and Company
  • Pfizer Inc.
  • CB Biosciences Inc.
  • Hoffmann-La Roche Ltd.
  • Merck & Co. Inc.
  • AstraZeneca plc
  • Sanofi SA
  • Otsuka Pharmaceutical Co. Ltd.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Bayer AG
  • Abbott Laboratories
  • Eisai Inc.
  • Janssen Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences Inc.
  • GlaxoSmithKline plc
  • LEO Pharma A/S
  • Regeneron Pharmaceuticals Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International Inc.
  • Chugai Pharmaceutical Co. Ltd.
  • Kyowa Kirin Co. Ltd.

Methodology

Loading
LOADING...